Noticeboard

The Gupta Family Endowed Award for Innovation in ALS Care is now accepting nominations.

This award is a global award to honor groundbreaking new approaches that lead to exceptional care for individuals living with ALS. The goal of this award is to encourage idea sharing, innovation, and forward-thinking on scalable ongoing and groundbreaking projects that have directly improved ALS patient care. It is awarded to a nominated team who has developed promising new approaches to improving care for people living with ALS.

The award will be presented at the NEALS Annual Meeting in October 28-30, 2026. The selected nominee will be awarded $40,000 USD and travel reimbursement up to $2,500 USD to attend the NEALS meeting.

Application deadline: 27 May

Find out more and apply

The Advancing Treatments Award funded by the My Name'5 Doddie Foundation is now accepting applications.

This award backs the early-stage development of new treatments designed to slow, stop, or reverse the progression of MND and better manage symptoms. The aim is to help build the data packages needed to attract onward investment and strategic partnerships. Awards are for a maximum of £500k for up to 5 years. They are looking for projects in two key areas: validating therapeutic targets and accelerating new treatments.

If the expression of interest application is selected, you will be invited to submit a full application and receive the award decision in November.

Application Deadline: 09 June

Find out more and apply

The Sean. M. Healey & AMG Center for ALS is accepting nominations for the 2026 Drs. Ayeez and Shelena Lalji & Family ALS Student Scholar Award for Repair and Regenerative Mechanisms in ALS.

This award will recognise and attract the brightest young scientists into the field of ALS and facilitate meaningful research to understand the mechanisms underlying axonal and neuronal repair and regeneration in ALS and/or other neurodegenerative disorders that may be translatable to ALS.

This award is open to undergraduate, graduate, or summer students conducting research under the direction of a mentor. Applications must be accompanied by a letter of support from the mentor who oversees the laboratory where the research will be performed.

The award will be presented at the NEALS Annual Meeting in October 28-30, 2026. The selected nominee will be awarded $5,000 USD.

Application deadline: 20 June

Find out more and apply

The Corsalex Postdoctoral Fellowship Program is designed to support promising early-career researchers who wish to enter or continue research in the field of C9orf72 MND/FTD. Fellows receive up to $210,000 over 3 years to support research of high scientific merit and relevance to C9 MND. Applications are open to Junior postdoctoral researchers with a designated advisor in an ALS or FTD-focused lab. Researchers must be no more than 1 year into postdoctoral fellowship. Corsalex are interested in projects that focus on:
The underlying biology of C9orf72 MND/FTD
Novel drug targets or biomarkers
Gene therapies
Drug delivery into the CNS
Disease models
 

Application Deadline: 01 July

Find out more and apply

The Sean M. Healey International Prize for Innovation in ALS is now accepting nominations. This is a global prize celebrating excellence in research for a team of investigators who catalyse exceptional discoveries leading to a transformative advance in therapy development in ALS.

The award will be presented at the International Symposium on ALS/MND in Amsterdam on the 9-11 December 2026. The selected nominee will be awarded $50,000 USD and travel reimbursement up to $2,500 USD to attend International Symposium on ALS/MND.

Prize Criteria:

Team of investigators who made a significant advance in the ALS field impacting the development of novel therapies for ALS, including, but not limited to the following:

• A technology to identify novel targets for drug development
• A technology to advance therapy development for ALS
• Tools or targets to stratify the ALS population and improve clinical trial design
• A global, multiple disciplinary collaboration that leads to new insights into the biology of the disease and translates into novel approaches for therapy development
• A novel outcome measure to improve efficiency in clinical trials in patients with ALS

Application deadine: 9 July

Find out more and apply

The Lalji Family ALS Award is accepting nominations for individual or team of investigators who have made significant progress impacting the repair and regeneration of neuronal degeneration that may be applied in ALS.

This is a global award celebrating excellence in research for an individual or team of investigators who are making transformative breakthroughs in the science of repair and regeneration of neurological function.

The award will be presented at the International Symposium on ALS/MND in Amsterdam on the 9-11 December 2026. The selected nominee will be awarded $40,000 USD.

Prize Criteria

• Applicant must have an MD, PhD or equivalent degree and be a leader in the field of ALS or regenerative medicine/biology with a strong publication record.
• The proposal must have a strong scientific rationale with a focus on repair of neurological function.
• Inclusion of preliminary findings demonstrating approach and feasibility in pre-clinical models is recommended.
• International applicants are encouraged to apply.

Application deadline: 3 September

Find out more and apply

The Radala Foundation is looking for established, leading principal investigators eligible for 200,000 CHF (~£181,500 GBP) research funding to pursue a potentially ground-breaking, high-risk project for 2 years in basic research in ALS.

Principal Investigators (PI) are expected to be active researchers who have a track-record of significant research achievements in the last 5 years. Investigators active in ALS research or in broadly related fields are encouraged to submit proposals relevant to ALS. Research must be conducted in a public or private research organisation (known as a host institution).

The goal of the Radala foundation is to provide research grants for the study of the understanding of the basic causes of the disease. These awards are not directed to clinically related projects for patient care. There is no geographical limitation to the recipients of these grants. 

Application deadline: 30 September

Find out more and apply

University College London are holding a three day course to provide the latest updates on neuromuscular disorders. The course covers a wide range of childhood and adult neuromuscular disorders with an emphasis on diagnosis, genetic testing, disease specific treatments and general management.  It is designed for specialists with an interest in neuromuscular diseases, and will also be relevant to anyone wishing to update their knowledge of 
neuromuscular diseases such as neurology trainees, consultants or other clinicians working with neuromuscular patients. 

This course is being held from the 13-15 May at Queen Square, London. 

Find out more and register

The European Network for the Cure of ALS (ENCALS) aims to develop a European trial network and initiate collaborations in Europe. Membership is open to Universities/Hospitals in Europe with ALS clinical/research activity. The ENCALS 2026 meeting will be held in Madrid, Spain from 24 to 26 June. Abstract submission deadline: 15 March 2026

Find out more and register

The 7th UCL Queen Square Motor Neuron Disease Centre International Symposium will be held in person at Queen Square in London on Friday 11th September 2026 from 09:30am to 5:40pm (GMT).

The programme includes talks on a range of topics from clincial trial updates to the development of new gene therapies and new targets for therapies in the future. 

Registration is free.

Find out more and register

The key to defeating MND lies in fostering strong collaboration between leading researchers around the world, and sharing new understanding of the disease as rapidly as possible. This was the MND Association’s rationale behind the creation of the International Symposium on ALS/MND.

Each year, the Symposium attracts over 1,000 delegates, representing the energy and dynamism of the global MND research community. It is the largest medical and scientific conference specific to MND/ALS and is the premier event in the MND research calendar for discussion on the latest advances in research and clinical management. 

The 37th Symposium will be held in Amsterdam in the Netherlands from the 9-11 December 2026.

Find out more